Among the blood samples, 113 sites were more accessible in peripheral CD4 T cells from IBD patients compared with 83 sites that were more accessible in peripheral CD4 T cells from healthy donors (Figure 1B). This evidence concerns the gene CD4 and inflammatory bowel disease.